If I’d invested £1k in Scottish Mortgage shares a year ago, here’s how much I’d have now!

Scottish Mortgage shares have had an infamously bad year. But it’s surging again and its prospects are looking up.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Scottish Mortgage Investment Trust (LSE:SMT) shares tanked in 2022 so I was glad I was among those investors who’d steered clear of the stock at its peak. The growth-focused investment trust fell even faster than it gained.

But things appear to be changing, so let’s take a closer look at Scottish Mortgage’s fortunes and why I’ve now bought it.

A tough year

If I’d invested £1,000 in Scottish Mortgage shares a year ago, today I’d be left with £580. That’s not a good return at all. But the share price is actually up 10% over the past month. So, last month, my £1,000 investment would have been worth only £520.

The fund’s falling share price reflects the decreasing value of the shares it holds.

Scottish Mortgage is weighted towards growth and tech stocks while having significant exposure to American, Chinese and unlisted shares.

And as we all know, growth stocks haven’t done too well over the past year. Illumina, which is one of the trust’s biggest holdings, is down 61% over the past year. And that’s pretty indicative of the market.

The bull case

I bought Scottish Mortgage stock for my SIPP when it fell to 700p a share last month. For me, it seemed like the natural turning point for the trust despite conditions for growth stocks not really improving.

Valuations for growth stocks have become particularly attractive, in my opinion. Tesla, one of Scottish Mortgage’s largest holdings, has fallen significantly despite the business continuing to grow. It currently has a price-to-sales (P/S) ratio of around 12.5, which is massively down on where it was a year ago.

This is reflected in Scottish Mortgage’s top 10 shares. Every single top-10 stock is down over the year while their core data hasn’t necessarily suffered. The tanking share prices simply reflected the sentiment that growth stocks were becoming too expensive.

Chinese EV maker NIO is another good example of this. The share price collapsed, but it now trades with a price-to-sales ratio of just 5.5. That’s particularly cheap considering the impressive growth curve it has been on.

But Scottish Mortgage also has a great track record for picking the next big thing before we’ve even heard of it. I know that sounds pretty vague, but it’s true. The next big growth stock could already be in its portfolio.

Risks

Of course, the current environment, characterised by higher interest rates and a slowdown in the global economy, isn’t good for growth stocks.

Higher rates mean the cost of growth is likely to increase. This is because such stocks normally have to borrow heavily to fund their expansion. That said, Scottish Mortgage biotech holding Moderna has so much cash lying around from the sale of its Covid-19 vaccine, it certainly won’t need to borrow.

I’m buying Scottish Mortgage

Fees and taxes included, I’m up around 7% on Scottish Mortgage. Not a lot of people can say that right now.

But I’m a long-term investor, and I still see a lot of potential at the current price. Growth stock valuations are much more attractive right now, and I’m backing Scottish Mortgage to pick the next generation of big winners.

James Fox has shares in NIO and Scottish Mortgage. The Motley Fool UK has recommended Tesla. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »